A comparison between willingness to pay and willingness to give up time

European Journal of Health Economics

Volumn 10, Issue 1, 2009, Pages 81-91

  Van Helvoort Postulart, Debby ^a   Dirksen, Carmen D ^a   Kessels, Alfons G H ^a   Van Engelshoven, Jos M A ^a   Myriam Hunink, M G ^b,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cost benefit analysis; Health economics; Utilities and preferences; Willingness to pay

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HEALTH CARE COST; HUMAN; HYPERTENSION; INTERVIEW; KIDNEY ARTERY STENOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; TIME;

ADULT; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; COHORT STUDIES; DECISION MAKING; FEMALE; HEALTH EXPENDITURES; HUMANS; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PATIENT PARTICIPATION; QUESTIONNAIRES; RENAL ARTERY OBSTRUCTION; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 58149101017     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-008-0105-6     Document Type: Article

References (40)

1. G.W. Torrance 1986 Measurement of health state utilities for economic appraisal J. Health. Econ 5 1 30
2. B. O'Brien A. Gafni 1996 When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care Med. Decis. Making 16 288 299
3. K. Arrow R. Solow E. Leamer P. Portney R. Randner H. Schuman 1993 Report of the NOAA panel on contingent valuation Fed. Regist 58 4602 4614
4. B. O'Brien J.L. Viramontes 1994 Willingness to pay: a valid and reliable measure of health state preference Med. Decis. Making 14 289 297
5. K. Blumenschein M. Johannesson 1998 Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma Ann. Allergy. Asthma. Immunol 80 189 194
6. A.J. Zillich K. Blumenschein M. Johannesson P. Freeman 2002 Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthma Pharmacoeconomics 20 257 265
7. C. Donaldson P. Shackley M. Abdalla Z. Miedzybrodzka 1995 Willingness to pay for antenatal carrier screening for cystic fibrosis Health. Econ 4 439 452
8. M. Ryan J. Ratcliffe J. Tucker 1997 Using willingness to pay to value alternative models of antenatal care Soc. Sci. Med 44 371 380
9. C. Donaldson P. Shackley M. Abdalla 1997 Using willingness to pay to value close substitutes: carrier screening for cystic fibrosis revisited Health. Econ 6 145 159
10. M. Johannesson B. Jönsson 1991 Economic evaluation in health care: Is there a role for cost-benefit analysis? Health. Policy 17 1 23
11. M. Johannesson 1992 Economic evaluation of lipid lowering-a feasibility test of the contingent valuation approach Health. Policy 20 309 320
12. J.C. Barner H.L. Mason M.D. Murray 1999 Assessment of asthma patients' willingness to pay for and give time to an asthma self-management program Clin. Ther 21 878 894
13. Visser, K.: Patient preferences for MR angiography, duplex US, and DSA in the work-up of peripheral arterial disease. Dissertation, Rotterdam (2001)
14. D.D. Kidney L. Deutsch 1996 The indications and results of percutaneous transluminal angioplasty and stenting in renal artery stenosis Semin. Vasc. Surg 9 188 197
15. S.J. Hessel D.F. Adams H.L. Abrams 1981 Complications of angiography Radiology 138 273 281
16. J.R. Waugh N. Sacharias 1992 Arteriographic complications in the DSA era Radiology 182 243 246
17. N. Young K.K. Chi J. Ajaka L. McKay D. O'Neill K.P. Wong 2002 Complications with outpatient angiography and interventional procedures Cardiovasc. Intervent. Radiol 25 123 126
18. M.R. Rudnick J.S. Berns R.M. Cohen S. Goldfarb 1994 Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism-a critical review Am. J. Kidney. Dis 24 713 727
19. S.T. Cochran K. Bomyea J.W. Sayre 2001 Trends in adverse events after IV administration of contrast media AJR. Am. J. Roentgenol 176 1385 1388
20. Working Group on Renovascular Hypertension. Detection, evaluation, and treatment of renovascular hypertension. Final report. Arch. Intern. Med. 147, 820-829 (1987)
21. G.B.C Vasbinder P.J. Nelemans A.G.H Kessels 2004 For the Renal Artery Diagnostic Imaging Study in Hypertension (RADISH) Study Group. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis Ann. Intern. Med 141 674 682
22. K. Blumenschein M. Johannesson 1999 Use of contingent valuation to place a monetary value on pharmacy services: an overview and review of the literature Clin. Ther 21 1402 1417
23. S.G. Patel D.A. Collie J.M. Wardlaw 2002 Outcome, observer reliability, and patient preferences if CTA, MRA, or Doppler ultrasound were used, individually or together, instead of digital subtraction angiography before carotid endarterectomy J. Neurol. Neurosurg. Psychiatry 73 21 28
24. J.S. Swan D.G. Fryback W.F. Lawrence 1997 MR and conventional angiography: work in progress toward assessing utility in radiology Acad. Radiol 4 475 482
25. J.S. Swan D.G. Fryback W.F. Lawrence F. Sainfort M.E. Hagenauer D.M. Heisey 2000 A time-tradeoff method for cost-effectiveness models applied to radiology Med. Decis. Making 20 79 88
26. J.M. Im R. Trivedi J. Cross 2004 Conventional digital subtraction x-ray angiography versus magnetic resonance angiography in the evaluation of carotid disease: patient satisfaction and preferences Clin. Radiol 59 358 363
27. Flowers, C.R., Garber, A.M., Bergen, M.R., Lenert, L.A.: Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems. In: Proceedings of AMIA Annual Fall Symposium, pp. 223-227 (1997)
28. H. Dong B. Kouyate J. Cairns R. Sauerborn 2003 A comparison of the reliability of the take-it-or-leave-it and the bidding game approaches to estimating willingness-to-pay in a rural population in West Africa Soc. Sci. Med 56 2181 2189
29. O. Onwujekwe J. Fox Rushby K. Hanson 2005 Inter-rater and test-retest reliability of three contingent valuation question formats in south-east Nigeria Health. Econ 14 529 536
30. Raad voor de Volksgezondheid en Zorg (Council for Public Health and Health Care). Exploderende zorguitgaven: signalement over uitgavenmanagement. Sig 03/01. Zoetermeer, The Netherlands, (2003)
31. M. Johannesson P-O. Johansson B. Kriström L. Borgquist B. Jönsson 1993 Willingness to pay for lipid lowering: a health production function approach Appl. Econ 25 1023 1031
32. P.J. Neumann M. Johannesson 1994 The willingness to pay for in vitro fertilization: a pilot study using contingent valuation Med. Care 32 686 699
33. L.G. Chestnut M.L. Keller W.E. Lambert R.D. Rowe 1996 Measuring heart patients' willingness to pay for changes in angina symptoms Med. Decis. Making 16 65 77
34. B. Kartman F. Andersson M. Johannesson 1996 Willingness to pay for reductions in angina pectoris attacks Med. Decis. Making 16 248 253
35. C. Donaldson P. Shackley 1997 Does "process" utility exist? A case study of willingness to pay for laparoscopic cholecystectomy Soc. Sci. Med 44 699 707
36. S.J. Lee B. Liljas P.J. Neumann M.C. Weinstein M. Johannesson 1998 The impact of risk information on patients' willingness to pay for autologous blood donation Med. Care 36 1162 1173
37. S.R. Eastaugh 2000 Willingness to pay in treatment of bleeding disorders Int. J. Technol. Assess. Health. Care 16 706 710
38. E. Dalmau Matarrodona 2001 Alternative approaches to obtain optimal bid values in contingent valuation studies and to model protest zeros. Estimating the determinants of individuals' willingness to pay for home care services in day case surgery Health. Econ 10 101 118
39. E. Frew J.L. Wolstenholme D.K. Whynes 2001 Willingness-to-pay for colorectal cancer screening Eur. J. Cancer 37 1746 1751
40. R.J. Jacobs R.J. Moleski A.S. Meyerhoff 2002 Valuation of symptomatic hepatitis A in adults: estimates based on time trade-off and willingness-to-pay measurement Pharmacoeconomics 20 739 747